[HTML][HTML] Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, I Hagelstein, C Hinterleitner… - Annals of …, 2020 - Springer
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, I Hagelstein… - Annals of …, 2020 - pubmed.ncbi.nlm.nih.gov
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
Identification of CD318 (CDCP1) as novel prognostic marker in AML.
JS Heitmann, I Hagelstein, C Hinterleitner… - Annals of …, 2020 - europepmc.org
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
[引用][C] Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, I Hagelstein, C Hinterleitner… - Annals of …, 2020 - ub01.uni-tuebingen.de
Identification of CD318 (CDCP1) as novel prognostic marker in AML Identification of CD318
(CDCP1) as novel prognostic marker in AML DSpace Repositorium (Manakin basiert) …
(CDCP1) as novel prognostic marker in AML DSpace Repositorium (Manakin basiert) …
[HTML][HTML] Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, I Hagelstein, C Hinterleitner… - Annals of …, 2020 - ncbi.nlm.nih.gov
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, H Ilona, H Clemens, R Malte… - Annals of …, 2020 - search.proquest.com
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
[引用][C] Identification of CD318 (CDCP1) as novel prognostic marker in AML
JS Heitmann, I Hagelstein… - Annals of …, 2020 - tobias-lib.ub.uni-tuebingen.de
Identification of CD318 (CDCP1) as novel prognostic marker in AML Identification of CD318
(CDCP1) as novel prognostic marker in AML DSpace Repositorium (Manakin basiert) …
(CDCP1) as novel prognostic marker in AML DSpace Repositorium (Manakin basiert) …
Identification of CD318 (CDCP1) as novel prognostic marker in AML.
JS Heitmann, I Hagelstein, C Hinterleitner… - Annals of …, 2020 - europepmc.org
Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …
leukemia (AML). However, further reliable markers are urgently needed to improve risk …